itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of Apple Have Risen Above Previou...

Apple (NASDAQ:AAPL) traded at a new 52-week high today of $120.00. Approximately 55.9 ...

Next Support Level for Agilent Technolog...

Shares of Agilent Technologies (NYSE:A) opened today below their pivot of $38.21 and ha ...

Volume Spike Detected in Shares of Apple...

Shares of Apple are trading up 7.1% to $116.91 today on above average volume. About 10 ...

Next Resistance Level for Alcoa (AA) is ...

Shares of Alcoa (NYSE:AA) opened today above their pivot of $15.90 and have already rea ...

Bearish Moving Average Cross by Agilent ...

Agilent Technologies (NYSE:A) crossed under its 10-day moving average of $38.61 on a vo ...

Stock Investors Sell Off Shares of Apple...

Apple (NASDAQ:AAPL) is one of today's biggest movers, down 2.5% to $110.31. The S&P is ...

Buyers Accumulate Shares of Alcoa, Up 1....

Alcoa (NYSE:AA) is one of today's biggest movers, up 1.6% to $16.02. The Dow is down 0 ...

Shares of PRG-Schultz International Unde...

PRG-Schultz International (NASDAQ:PRGX) is one of today's biggest movers, down 1.7% to ...

Most Popular Video News